Befiradol (NLX-112) |
| Catalog No.GC31113 |
Befiradol (NLX-112) (NLX-112) is a selective 5-HT1A receptor agonist.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 208110-64-9
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Befiradol (NLX-112) is a selective 5-HT1A receptor agonist.
[1]. Lladó-Pelfort L, et al. In vivo electrophysiological and neurochemical effects of the selective 5-HT1A receptor agonist, F13640, at pre- and postsynaptic 5-HT1A receptors in the rat. Psychopharmacology (Berl). 2012 May;221(2):261-72.
Review for Befiradol (NLX-112)
Average Rating: 5 (Based on Reviews and 9 reference(s) in Google Scholar.)
Review for Befiradol (NLX-112)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *